LDL-cholesterol drives reversible myelomonocytic skewing in human bone marrow-Reference-Cited by-同舟云学术

LDL-cholesterol drives reversible myelomonocytic skewing in human bone marrow

Published:2021-09-11 Issue:42 Volume:42 Page:4321-4323
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Yvan-Charvet Laurent¹^ORCID,Westerterp Marit²^ORCID

Affiliation:

1. Institut National de la Santé et de la Recherche Médicale (INSERM) U1065, Université Côte d’Azur, Centre Méditerranéen de Médecine Moléculaire (C3M), Atip-Avenir, Fédération Hospitalo-Universitaire (FHU) Oncoage, Nice, France

2. Department of Pediatrics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

Funder

Fondation de France

National Agency for Research

European Research Council

Netherlands Organization of Scientific Research

University of Groningen

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

https://academic.oup.com/eurheartj/article-pdf/42/42/4321/41099650/ehab630.pdf

Reference19 articles.

1. Impact of cholesterol on proinflammatory monocyte production by the bone marrow;Stiekema;Eur Heart J,2021

2. Effects of dyslipidaemia on monocyte production and function in cardiovascular disease;Rahman;Nat Rev Cardiol,2017

3. Is defective cholesterol efflux an integral inflammatory component in myelopoiesis-driven cardiovascular diseases?;Yvan-Charvet;Eur Heart J,2018

4. ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation;Yvan-Charvet;Science,2010

5. ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice;Murphy;J Clin Invest,2011

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-density lipoproteins, lipoprotein(a), and remnant cholesterol: new opportunities for reducing residual cardiovascular risk;European Heart Journal;2023-04-21

2. New therapeutic targets to reduce inflammation-associated cardiovascular risk: the CCL2–CCR2 axis, LOX-1, and IRF5;European Heart Journal;2022-05-14

3. New targets in vascular biology and new challenges in vascular medicine;European Heart Journal;2021-11-07